ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3054% below fair value
$71.44+0.38 (+0.53%)
Close on Nov 13, 2026Market cap $1.64BP/E 13.5Yield –
ANI Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ANI Pharmaceuticals's enterprise value was $1.48B on Nov 11, 2026, against $1.77B a year earlier. Over the last 5 years it ranged from $541.14M to $1.95B, with a median of $1.27B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.48B | -10.0% |
| 2025 | Dec 31, 2025 | $1.65B | +32.2% |
| 2024 | Dec 31, 2024 | $1.25B | +18.0% |
| 2023 | Dec 29, 2023 | $1.06B | +22.3% |
| 2022 | Dec 30, 2022 | $863.05M | +16.3% |
| 2021 | Dec 31, 2021 | $742.07M | +43.4% |
| 2020 | Dec 31, 2020 | $517.45M | -30.9% |
| 2019 | Dec 31, 2019 | $748.84M | +36.0% |
| 2018 | Dec 31, 2018 | $550.74M | -24.9% |
| 2017 | Dec 29, 2017 | $733.34M | +7.2% |
| 2016 | Dec 30, 2016 | $684.10M | +84.2% |
| 2015 | Dec 31, 2015 | $371.37M | +372.9% |
| 2013 | Jan 31, 2013 | $78.53M | +13.0% |
| 2012 | Dec 31, 2012 | $69.48M | -64.6% |
| 2011 | Dec 30, 2011 | $196.32M | -35.5% |
| 2010 | Dec 31, 2010 | $304.23M | – |
See a number that looks wrong?